10x Genomics stock slides 14% amid Illumina deal, Deutsche downgrade (NASDAQ:TXG)
2024-07-10
Sundry Photography 10x Genomics (NASDAQ:TXG) stock slid 14% Wednesday amid news that Illumina (ILMN) has acquired single cell analysis technology company Fluent BioSciences and a downgrade by Deutsche Bank. The investment bank cut its rating of 10x Genomics to hold, stating that heightened competition was “eroding the inelastic demand thatContinue Reading